Sabba Stephen L
Insider CIK 1442372 · QLT Director · LGND Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-06-16 | 2026-06-18 | 2,145 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-16 | 2026-06-18 | 2,145 | $254.00 | $544.8K | 33,629 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-06-16 | 2026-06-18 | 2,145 | $66.13 | $141.8K | 35,774 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-06-05 | 2026-06-09 | 2,938 | — | $0 | 2,938 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-06-05 | 2026-06-09 | 836 | — | $0 | 33,629 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-23 | 2026-03-25 | 1,000 | $207.87 | $207.9K | 32,793 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2026-03-03 | 2026-03-05 | 2,034 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-03-03 | 2026-03-05 | 2,034 | $201.50 | $409.9K | 33,793 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2026-03-03 | 2026-03-05 | 2,034 | $69.51 | $141.4K | 35,827 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-06-06 | 2025-06-10 | 5,783 | — | $0 | 5,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-06-06 | 2025-06-10 | 1,209 | — | $0 | 33,793 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-04-01 | 2025-04-16 | 2,406 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-04-01 | 2025-04-16 | 2,406 | $52.30 | $125.8K | 32,584 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-06-14 | 2024-06-25 | 5,444 | — | $0 | 5,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-06-14 | 2024-06-25 | 1,252 | — | $0 | 30,178 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-03-05 | 2024-03-07 | 2,893 | — | $0 | 419 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2024-03-05 | 2024-03-07 | 1,893 | $74.30 | $140.6K | 28,926 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-03-05 | 2024-03-07 | 2,893 | — | $0 | 30,819 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-06-09 | 2023-06-21 | 5,461 | — | $0 | 5,461 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-06-09 | 2023-06-21 | 1,142 | — | $0 | 26,926 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2023-05-10 | 2023-05-12 | 6,408 | — | $0 | 927 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2023-05-10 | 2023-05-12 | 6,408 | — | $0 | 32,192 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2023-05-10 | 2023-05-12 | 6,408 | $77.13 | $494.2K | 25,784 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 6,623 | — | $0 | 6,623 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-14 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-14 | 1,004 | — | $0 | 26,065 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-08 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-08 | 630 | — | $0 | 25,061 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-09 | 2021-02-11 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2021-02-09 | 2021-02-11 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-02-09 | 2021-02-11 | 556 | $208.00 | $115.6K | 38,545 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-09 | 2021-02-11 | 7,335 | $12.53 | $91.9K | 39,101 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2021-02-09 | 2021-02-11 | 7,335 | $10.12 | $74.2K | 31,766 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2021-02-09 | 2021-02-11 | 14,114 | $208.55 | $2.94M | 24,431 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 24,431 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2019-07-31 | 2019-08-01 | 4,091 | $94.45 | $386.4K | 23,600 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-06-06 | 2019-06-10 | 4,071 | — | $0 | 4,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-06-06 | 2019-06-10 | 835 | — | $0 | 27,691 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-06 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-06 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-06 | 2,500 | $8.58 | $21.4K | 29,356 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-09-04 | 2018-09-06 | 5,000 | $255.05 | $1.28M | 26,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-06 | 2,500 | $17.88 | $44.7K | 31,856 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-08-09 | 2018-08-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-07-03 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-07-03 | 493 | — | $0 | 26,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-06-21 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-06-21 | 493 | — | $0 | 26,856 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-03-12 | 2018-03-13 | 622 | $180.73 | $112.4K | 26,363 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-12-20 | 2017-12-21 | 925 | $137.25 | $127.0K | 26,985 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-05-25 | 2017-05-30 | 2,456 | — | $0 | 2,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-05-25 | 2017-05-30 | 666 | — | $0 | 27,910 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2016-12-22 | 2016-12-27 | 9,600 | — | $0 | 9,600 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 6,400 | — | $0 | 28,400 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-05-23 | 2016-05-25 | 2,329 | — | $0 | 2,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 622 | — | $0 | 27,244 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-29 | 2015-07-01 | 12,500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-29 | 2015-07-01 | 12,500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-29 | 2015-07-01 | 12,500 | $3.67 | $45.9K | 24,500 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-29 | 2015-07-01 | 12,500 | $3.30 | $41.3K | 37,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 4,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 6,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 4,000 | — | $0 | 6,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 6,000 | — | $0 | 12,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-04-24 | 2015-04-28 | 2,754 | — | $0 | 2,754 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-28 | 925 | — | $0 | 26,622 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 2,000 | — | $0 | 4,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2014-12-15 | 2014-12-17 | 2,000 | — | $0 | 2,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-10-09 | 2014-10-10 | 2,000 | $43.12 | $86.2K | 23,697 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2014-10-09 | 2014-10-14 | 2,000 | $43.12 | $86.2K | 23,697 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-06-04 | 2014-06-06 | 3,312 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-06 | 1,151 | — | $0 | 21,697 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-27 | 2014-02-28 | 500 | $72.25 | $36.1K | 20,546 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-06-11 | 2013-06-13 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-13 | 3,621 | — | $0 | 21,046 | SEC↗ |
| QLT QLT INC/BC | A Award deriv | 2012-07-10 | 2012-07-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-06-01 | 2012-06-04 | 2,000 | $12.02 | $24.0K | 17,425 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-05-31 | 2012-06-04 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-06-04 | 4,721 | — | $0 | 15,425 | SEC↗ |